Briquilimab-Based Nonmyeloablative Conditioning in Older Adults with High-Risk AML/MDS – Resonance
The ALRCaN Global webinar, “Nonmyeloablative Conditioning Combined with the Anti-CD117 Antibody Briquilimab in Older Adults with High-Risk AML and MDS,” is scheduled for Friday, September 11, 2026, from 9:00 AM […]